{"entity":{"type":"insider","cik":"0001753224","url":"/insider/0001753224","json_url":"/insider/0001753224.json","name":"Gad Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":124,"n_filings":87,"first":"2019-04-11","last":"2025-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Gad Thomas","source":"filing","n_filings":87,"first_seen":"2019-04-11","last_seen":"2025-03-11"}],"transactions":[{"id":4500590,"accession":"0001415889-25-007737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007737","line_url":"/filing/0001415889-25-007737#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10810.0,"shares_display":"10,810","price_per_share":5.23,"price_display":"5.23","price_state":"stated","total_value":56536.3,"total_display":"56,536.30","total_whole":"56,536","shares_owned_after":202721.0,"shares_owned_after_display":"202,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider"},{"id":3086898,"accession":"0001415889-24-023554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023554","line_url":"/filing/0001415889-24-023554#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.97,"price_display":"12.97","price_state":"stated","total_value":389100.0,"total_display":"389,100.00","total_whole":"389,100","shares_owned_after":67681.0,"shares_owned_after_display":"67,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":3086894,"accession":"0001415889-24-023554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023554","line_url":"/filing/0001415889-24-023554#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":13.47,"price_display":"13.47","price_state":"stated","total_value":875550.0,"total_display":"875,550.00","total_whole":"875,550","shares_owned_after":97681.0,"shares_owned_after_display":"97,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider"},{"id":2353699,"accession":"0001104659-24-070532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-070532","line_url":"/filing/0001104659-24-070532#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":162681.0,"shares_owned_after_display":"162,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider"},{"id":2353695,"accession":"0001104659-24-070532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-070532","line_url":"/filing/0001104659-24-070532#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":421050.0,"total_display":"421,050.00","total_whole":"421,050","shares_owned_after":197681.0,"shares_owned_after_display":"197,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2685764,"accession":"0001104659-24-064808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-064808","line_url":"/filing/0001104659-24-064808#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7351.0,"shares_display":"7,351","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":95563.0,"total_display":"95,563.00","total_whole":"95,563","shares_owned_after":232681.0,"shares_owned_after_display":"232,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-23","scope":"insider"},{"id":2685760,"accession":"0001104659-24-064808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-064808","line_url":"/filing/0001104659-24-064808#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":240032.0,"shares_owned_after_display":"240,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-23","scope":"insider"},{"id":3153819,"accession":"0001104659-24-031941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-031941","line_url":"/filing/0001104659-24-031941#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (CHIEF BUSINESS OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":64116.0,"total_display":"64,116.00","total_whole":"64,116","shares_owned_after":158700.0,"shares_owned_after_display":"158,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":8073537,"accession":"0001104659-23-126508","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-126508","line_url":"/filing/0001104659-23-126508#line-3","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.61,"price_display":"6.61","price_state":"stated","total_value":330500.0,"total_display":"330,500.00","total_whole":"330,500","shares_owned_after":265032.0,"shares_owned_after_display":"265,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-15","scope":"insider"},{"id":8073533,"accession":"0001104659-23-126508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-126508","line_url":"/filing/0001104659-23-126508#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":341500.0,"total_display":"341,500.00","total_whole":"341,500","shares_owned_after":315032.0,"shares_owned_after_display":"315,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-15","scope":"insider"},{"id":8073527,"accession":"0001104659-23-126508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-126508","line_url":"/filing/0001104659-23-126508#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.58,"price_display":"6.58","price_state":"stated","total_value":329000.0,"total_display":"329,000.00","total_whole":"329,000","shares_owned_after":365032.0,"shares_owned_after_display":"365,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":8014981,"accession":"0001104659-23-120804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-120804","line_url":"/filing/0001104659-23-120804#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":5.3065,"price_display":"5.31","price_state":"stated","total_value":397987.5,"total_display":"397,987.50","total_whole":"397,988","shares_owned_after":415032.0,"shares_owned_after_display":"415,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8014978,"accession":"0001104659-23-120804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-120804","line_url":"/filing/0001104659-23-120804#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer (Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":5.2986,"price_display":"5.30","price_state":"stated","total_value":397395.0,"total_display":"397,395.00","total_whole":"397,395","shares_owned_after":490032.0,"shares_owned_after_display":"490,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider"},{"id":6351224,"accession":"0001104659-22-017278","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-017278","line_url":"/filing/0001104659-22-017278#line-3","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64276.0,"shares_display":"64,276","price_per_share":6.9562,"price_display":"6.96","price_state":"stated","total_value":447116.7112,"total_display":"447,116.71","total_whole":"447,117","shares_owned_after":565032.0,"shares_owned_after_display":"565,032","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-09","scope":"insider"},{"id":6351222,"accession":"0001104659-22-017278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-017278","line_url":"/filing/0001104659-22-017278#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125863.0,"shares_display":"125,863","price_per_share":7.0147,"price_display":"7.01","price_state":"stated","total_value":882891.1861,"total_display":"882,891.19","total_whole":"882,891","shares_owned_after":629308.0,"shares_owned_after_display":"629,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6351219,"accession":"0001104659-22-017278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-017278","line_url":"/filing/0001104659-22-017278#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91031.0,"shares_display":"91,031","price_per_share":7.5928,"price_display":"7.59","price_state":"stated","total_value":691180.1768,"total_display":"691,180.18","total_whole":"691,180","shares_owned_after":755171.0,"shares_owned_after_display":"755,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":6808931,"accession":"0001104659-22-012868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-012868","line_url":"/filing/0001104659-22-012868#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101104.0,"shares_display":"101,104","price_per_share":7.7003,"price_display":"7.70","price_state":"stated","total_value":778531.1312,"total_display":"778,531.13","total_whole":"778,531","shares_owned_after":846202.0,"shares_owned_after_display":"846,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-07","scope":"insider"},{"id":6808927,"accession":"0001104659-22-012868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-012868","line_url":"/filing/0001104659-22-012868#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35060.0,"shares_display":"35,060","price_per_share":7.9015,"price_display":"7.90","price_state":"stated","total_value":277026.59,"total_display":"277,026.59","total_whole":"277,027","shares_owned_after":947306.0,"shares_owned_after_display":"947,306","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-07","scope":"insider"},{"id":6695938,"accession":"0001104659-22-011410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-011410","line_url":"/filing/0001104659-22-011410#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.1451,"price_display":"10.15","price_state":"stated","total_value":81160.8,"total_display":"81,160.80","total_whole":"81,161","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-03","scope":"insider"},{"id":6568820,"accession":"0001104659-22-007879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-007879","line_url":"/filing/0001104659-22-007879","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88055.0,"shares_display":"88,055","price_per_share":10.634398830276531,"price_display":"10.63","price_state":"stated","total_value":936411.989,"total_display":"936,411.99","total_whole":"936,412","shares_owned_after":982366.0,"shares_owned_after_display":"982,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-26","scope":"insider","n_lines":2},{"id":6597378,"accession":"0001104659-22-007020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-007020","line_url":"/filing/0001104659-22-007020","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70318.0,"shares_display":"70,318","price_per_share":10.748533038482323,"price_display":"10.75","price_state":"stated","total_value":755815.3462,"total_display":"755,815.35","total_whole":"755,815","shares_owned_after":1090605.0,"shares_owned_after_display":"1,090,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-24","scope":"insider","n_lines":2},{"id":6597364,"accession":"0001104659-22-007020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-007020","line_url":"/filing/0001104659-22-007020#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112767.0,"shares_display":"112,767","price_per_share":11.3268,"price_display":"11.33","price_state":"stated","total_value":1277289.2556,"total_display":"1,277,289.26","total_whole":"1,277,289","shares_owned_after":1140739.0,"shares_owned_after_display":"1,140,739","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-24","scope":"insider"},{"id":6770068,"accession":"0001104659-22-006024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-006024","line_url":"/filing/0001104659-22-006024#line-4","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69414.0,"shares_display":"69,414","price_per_share":10.8925,"price_display":"10.89","price_state":"stated","total_value":756091.995,"total_display":"756,092.00","total_whole":"756,092","shares_owned_after":1253506.0,"shares_owned_after_display":"1,253,506","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-20","scope":"insider"},{"id":6770065,"accession":"0001104659-22-006024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-006024","line_url":"/filing/0001104659-22-006024","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":11.53552380952381,"price_display":"11.54","price_state":"stated","total_value":96898.4,"total_display":"96,898.40","total_whole":"96,898","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-20","scope":"insider","n_lines":2},{"id":5404619,"accession":"0001104659-21-147696","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-147696","line_url":"/filing/0001104659-21-147696#line-3","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.5832,"price_display":"17.58","price_state":"stated","total_value":175832.0,"total_display":"175,832.00","total_whole":"175,832","shares_owned_after":1383320.0,"shares_owned_after_display":"1,383,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-08","scope":"insider"},{"id":5404615,"accession":"0001104659-21-147696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-147696","line_url":"/filing/0001104659-21-147696","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":16.482772727272728,"price_display":"16.48","price_state":"stated","total_value":725242.0,"total_display":"725,242.00","total_whole":"725,242","shares_owned_after":1397320.0,"shares_owned_after_display":"1,397,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-08","scope":"insider","n_lines":2},{"id":4988055,"accession":"0001104659-21-145532","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-21-145532","line_url":"/filing/0001104659-21-145532","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25170.0,"shares_display":"25,170","price_per_share":17.062280373460467,"price_display":"17.06","price_state":"stated","total_value":429457.597,"total_display":"429,457.60","total_whole":"429,458","shares_owned_after":1449090.0,"shares_owned_after_display":"1,449,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider","n_lines":4},{"id":4988041,"accession":"0001104659-21-145532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-145532","line_url":"/filing/0001104659-21-145532#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22437.0,"shares_display":"22,437","price_per_share":17.1603,"price_display":"17.16","price_state":"stated","total_value":385025.6511,"total_display":"385,025.65","total_whole":"385,026","shares_owned_after":1462490.0,"shares_owned_after_display":"1,462,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":4168604,"accession":"0001104659-21-144027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-144027","line_url":"/filing/0001104659-21-144027#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":17.057,"price_display":"17.06","price_state":"stated","total_value":852850.0,"total_display":"852,850.00","total_whole":"852,850","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-26","scope":"insider"},{"id":5502236,"accession":"0001104659-21-141274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-141274","line_url":"/filing/0001104659-21-141274#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.3255,"price_display":"19.33","price_state":"stated","total_value":77302.0,"total_display":"77,302.00","total_whole":"77,302","shares_owned_after":1484927.0,"shares_owned_after_display":"1,484,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":4877141,"accession":"0001104659-21-132432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-132432","line_url":"/filing/0001104659-21-132432#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":24.8152,"price_display":"24.82","price_state":"stated","total_value":99260.8,"total_display":"99,260.80","total_whole":"99,261","shares_owned_after":1488927.0,"shares_owned_after_display":"1,488,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-29","filed_date":"2021-11-01","scope":"insider"},{"id":4768874,"accession":"0001104659-21-127633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-127633","line_url":"/filing/0001104659-21-127633#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":27.1998,"price_display":"27.20","price_state":"stated","total_value":108799.2,"total_display":"108,799.20","total_whole":"108,799","shares_owned_after":1492927.0,"shares_owned_after_display":"1,492,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider"},{"id":4720854,"accession":"0001104659-21-122571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-122571","line_url":"/filing/0001104659-21-122571#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":28.2636,"price_display":"28.26","price_state":"stated","total_value":113054.4,"total_display":"113,054.40","total_whole":"113,054","shares_owned_after":1496927.0,"shares_owned_after_display":"1,496,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-10-04","scope":"insider"},{"id":5248172,"accession":"0001104659-21-116995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-116995","line_url":"/filing/0001104659-21-116995#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.6447,"price_display":"33.64","price_state":"stated","total_value":134578.8,"total_display":"134,578.80","total_whole":"134,579","shares_owned_after":1500927.0,"shares_owned_after_display":"1,500,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4948862,"accession":"0001104659-21-113493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-113493","line_url":"/filing/0001104659-21-113493#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":33.1783,"price_display":"33.18","price_state":"stated","total_value":1658915.0,"total_display":"1,658,915.00","total_whole":"1,658,915","shares_owned_after":1504927.0,"shares_owned_after_display":"1,504,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-07","scope":"insider"},{"id":5502073,"accession":"0001104659-21-107093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-107093","line_url":"/filing/0001104659-21-107093#line-4","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1779.0,"shares_display":"1,779","price_per_share":28.964,"price_display":"28.96","price_state":"stated","total_value":51526.956,"total_display":"51,526.96","total_whole":"51,527","shares_owned_after":1554927.0,"shares_owned_after_display":"1,554,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-17","scope":"insider"},{"id":5502071,"accession":"0001104659-21-107093","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-107093","line_url":"/filing/0001104659-21-107093","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26111.0,"shares_display":"26,111","price_per_share":29.300704128528206,"price_display":"29.30","price_state":"stated","total_value":765070.6855,"total_display":"765,070.69","total_whole":"765,071","shares_owned_after":1556706.0,"shares_owned_after_display":"1,556,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider","n_lines":2},{"id":5502067,"accession":"0001104659-21-107093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-107093","line_url":"/filing/0001104659-21-107093#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1110.0,"shares_display":"1,110","price_per_share":31.0141,"price_display":"31.01","price_state":"stated","total_value":34425.651,"total_display":"34,425.65","total_whole":"34,426","shares_owned_after":1582817.0,"shares_owned_after_display":"1,582,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-13","filed_date":"2021-08-17","scope":"insider"},{"id":4768599,"accession":"0001104659-21-100843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-100843","line_url":"/filing/0001104659-21-100843#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.7318,"price_display":"33.73","price_state":"stated","total_value":134927.2,"total_display":"134,927.20","total_whole":"134,927","shares_owned_after":1583927.0,"shares_owned_after_display":"1,583,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":4514679,"accession":"0001104659-21-094534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-094534","line_url":"/filing/0001104659-21-094534#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":32.4688,"price_display":"32.47","price_state":"stated","total_value":129875.2,"total_display":"129,875.20","total_whole":"129,875","shares_owned_after":1587927.0,"shares_owned_after_display":"1,587,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-21","scope":"insider"},{"id":4514647,"accession":"0001104659-21-090300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-090300","line_url":"/filing/0001104659-21-090300#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":31.8662,"price_display":"31.87","price_state":"stated","total_value":127464.8,"total_display":"127,464.80","total_whole":"127,465","shares_owned_after":1591927.0,"shares_owned_after_display":"1,591,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider"},{"id":5536311,"accession":"0001104659-21-088904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-088904","line_url":"/filing/0001104659-21-088904#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753224","owner_name":"Gad Thomas","owner_display_name":"Gad Thomas","owner_url":"/insider/0001753224","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.8614,"price_display":"33.86","price_state":"stated","total_value":135445.6,"total_display":"135,445.60","total_whole":"135,446","shares_owned_after":1595927.0,"shares_owned_after_display":"1,595,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-02","scope":"insider"}],"collapsed":true,"next_cursor":"2021-06-30|5536311","ledger_fault":false,"count":{"value":124,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":124,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":124},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Director, Officer (CHIEF BUSINESS OFFICER)","n_filings":87,"first_seen":"2019-04-11","last_seen":"2025-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753224","retrieved_at":"2026-08-26T19:04:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}